$1.27 Earnings Per Share Expected for Walgreens Boots Alliance Inc (WBA) This Quarter
Brokerages expect Walgreens Boots Alliance Inc (NASDAQ:WBA) to post earnings per share of $1.27 for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have provided estimates for Walgreens Boots Alliance’s earnings, with estimates ranging from $1.20 to $1.36. Walgreens Boots Alliance reported earnings of $1.10 per share during the same quarter last year, which indicates a positive year over year growth rate of 15.5%. The company is scheduled to issue its next earnings results before the market opens on Thursday, January 4th.
On average, analysts expect that Walgreens Boots Alliance will report full year earnings of $5.54 per share for the current financial year, with EPS estimates ranging from $5.45 to $5.70. For the next year, analysts forecast that the business will post earnings of $6.05 per share, with EPS estimates ranging from $5.87 to $6.20. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that that provide coverage for Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. During the same quarter last year, the firm earned $1.07 EPS. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year.
In related news, Director John Anthony Lederer purchased 20,000 shares of the stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is owned by company insiders.
Several large investors have recently bought and sold shares of the stock. Franklin Resources Inc. grew its stake in Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after buying an additional 3,662,302 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in Walgreens Boots Alliance by 471.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock valued at $258,077,000 after buying an additional 2,718,800 shares in the last quarter. Vanguard Group Inc. grew its stake in Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after buying an additional 1,926,108 shares in the last quarter. Wellington Management Group LLP grew its stake in Walgreens Boots Alliance by 5.9% in the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after buying an additional 1,824,300 shares in the last quarter. Finally, Glenview Capital Management LLC purchased a new position in Walgreens Boots Alliance in the 2nd quarter valued at approximately $136,875,000. 61.41% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance (WBA) opened at $71.94 on Friday. Walgreens Boots Alliance has a 1 year low of $63.82 and a 1 year high of $88.00. The firm has a market cap of $72,850.00, a PE ratio of 13.80, a P/E/G ratio of 1.25 and a beta of 1.22. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59.
Walgreens Boots Alliance declared that its board has approved a stock buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its shares are undervalued.
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were given a dividend of $0.40 per share. The ex-dividend date was Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.22%. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/17/1-27-earnings-per-share-expected-for-walgreens-boots-alliance-inc-wba-this-quarter.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related stocks with our FREE daily email newsletter.